MX359713B - Composiciones mejoradas para la cicatrizacion de heridas que comprenden microesferas. - Google Patents
Composiciones mejoradas para la cicatrizacion de heridas que comprenden microesferas.Info
- Publication number
- MX359713B MX359713B MX2015002816A MX2015002816A MX359713B MX 359713 B MX359713 B MX 359713B MX 2015002816 A MX2015002816 A MX 2015002816A MX 2015002816 A MX2015002816 A MX 2015002816A MX 359713 B MX359713 B MX 359713B
- Authority
- MX
- Mexico
- Prior art keywords
- microspheres
- wound healing
- healing compositions
- improved wound
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/745—Polymers of hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0014—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se proporcionan composiciones farmacéuticas o médicas para el tratamiento de una herida, la composición comprende microesferas como un ingrediente activo y agua como un portador para dichas microesferas. En algunas modalidades, se proporcionan composiciones que comprenden un agente espesante disuelto dentro del agua para formar una solución que tiene una gravedad específica similar a la de las microesferas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261700362P | 2012-09-13 | 2012-09-13 | |
PCT/IL2013/050774 WO2014041543A1 (en) | 2012-09-13 | 2013-09-12 | Improved wound healing compositions comprising microspheres |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2015002816A MX2015002816A (es) | 2015-05-15 |
MX359713B true MX359713B (es) | 2018-10-08 |
Family
ID=50277729
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015002816A MX359713B (es) | 2012-09-13 | 2013-09-12 | Composiciones mejoradas para la cicatrizacion de heridas que comprenden microesferas. |
Country Status (18)
Country | Link |
---|---|
US (1) | US9370533B2 (es) |
EP (1) | EP2895209B1 (es) |
JP (1) | JP6104390B2 (es) |
KR (1) | KR102200656B1 (es) |
AU (1) | AU2013316718B2 (es) |
BR (1) | BR112015005335B1 (es) |
CA (1) | CA2883455C (es) |
DK (1) | DK2895209T3 (es) |
ES (1) | ES2748805T3 (es) |
HK (1) | HK1212638A1 (es) |
HR (1) | HRP20191804T1 (es) |
HU (1) | HUE047212T2 (es) |
LT (1) | LT2895209T (es) |
MX (1) | MX359713B (es) |
PL (1) | PL2895209T3 (es) |
PT (1) | PT2895209T (es) |
RS (1) | RS59410B1 (es) |
WO (1) | WO2014041543A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6893877B2 (ja) * | 2014-10-29 | 2021-06-23 | スペクトラル エムディー, インコーポレイテッドSpectral Md, Inc. | 組織を分類するための反射モードマルチスペクトル時間分解型光学イメージングの方法および装置 |
CN110573066A (zh) | 2017-03-02 | 2019-12-13 | 光谱Md公司 | 用于多光谱截肢部位分析的机器学习系统和技术 |
WO2020123722A1 (en) | 2018-12-14 | 2020-06-18 | Spectral Md, Inc. | System and method for high precision multi-aperture spectral imaging |
BR112021011132A2 (pt) | 2018-12-14 | 2021-08-31 | Spectral Md, Inc. | Sistemas de aprendizado por máquina e métodos para avaliação, predição de cicatrização e tratamento de feridas |
US10740884B2 (en) | 2018-12-14 | 2020-08-11 | Spectral Md, Inc. | System and method for high precision multi-aperture spectral imaging |
US10783632B2 (en) | 2018-12-14 | 2020-09-22 | Spectral Md, Inc. | Machine learning systems and method for assessment, healing prediction, and treatment of wounds |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5614310A (en) * | 1994-11-04 | 1997-03-25 | Minnesota Mining And Manufacturing Company | Low trauma wound dressing with improved moisture vapor permeability |
US5861149A (en) * | 1997-06-04 | 1999-01-19 | Polyheal Ltd. | Methods for wound treatment |
EP1041970B1 (en) | 1998-10-23 | 2013-07-03 | Polyheal Ltd. | Compositions of microspheres for wound healing |
EP1368354A1 (en) * | 2001-03-07 | 2003-12-10 | Pfizer Products Inc. | Modulators of chemokine receptor activity |
US7465463B2 (en) | 2002-09-04 | 2008-12-16 | Polyheal, Ltd. | Compositions comprising microspheres with anti-inflammatory properties for healing of ocular tissues |
CN101378790A (zh) * | 2006-01-31 | 2009-03-04 | 大卫·瓦尚 | 用于促进多细胞生物的组织愈合的组合物和方法 |
GB0607774D0 (en) * | 2006-04-20 | 2006-05-31 | Renovo Group Plc | Medicaments |
-
2013
- 2013-09-12 AU AU2013316718A patent/AU2013316718B2/en active Active
- 2013-09-12 DK DK13838041.5T patent/DK2895209T3/da active
- 2013-09-12 PL PL13838041T patent/PL2895209T3/pl unknown
- 2013-09-12 WO PCT/IL2013/050774 patent/WO2014041543A1/en active Application Filing
- 2013-09-12 PT PT138380415T patent/PT2895209T/pt unknown
- 2013-09-12 LT LT13838041T patent/LT2895209T/lt unknown
- 2013-09-12 HU HUE13838041A patent/HUE047212T2/hu unknown
- 2013-09-12 ES ES13838041T patent/ES2748805T3/es active Active
- 2013-09-12 KR KR1020157009202A patent/KR102200656B1/ko active IP Right Grant
- 2013-09-12 RS RSP20191288 patent/RS59410B1/sr unknown
- 2013-09-12 CA CA2883455A patent/CA2883455C/en active Active
- 2013-09-12 BR BR112015005335-1A patent/BR112015005335B1/pt active IP Right Grant
- 2013-09-12 MX MX2015002816A patent/MX359713B/es active IP Right Grant
- 2013-09-12 EP EP13838041.5A patent/EP2895209B1/en active Active
- 2013-09-12 US US14/427,747 patent/US9370533B2/en active Active
- 2013-09-12 JP JP2015531687A patent/JP6104390B2/ja active Active
-
2016
- 2016-01-21 HK HK16100684.3A patent/HK1212638A1/zh unknown
-
2019
- 2019-10-03 HR HRP20191804TT patent/HRP20191804T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
US9370533B2 (en) | 2016-06-21 |
LT2895209T (lt) | 2019-10-25 |
PT2895209T (pt) | 2019-10-28 |
HUE047212T2 (hu) | 2020-04-28 |
US20150231170A1 (en) | 2015-08-20 |
PL2895209T3 (pl) | 2020-01-31 |
CA2883455C (en) | 2020-01-28 |
EP2895209A1 (en) | 2015-07-22 |
KR102200656B1 (ko) | 2021-01-11 |
ES2748805T3 (es) | 2020-03-18 |
CA2883455A1 (en) | 2014-03-20 |
RS59410B1 (sr) | 2019-11-29 |
AU2013316718B2 (en) | 2016-09-29 |
JP6104390B2 (ja) | 2017-03-29 |
BR112015005335A8 (pt) | 2018-01-30 |
EP2895209A4 (en) | 2016-04-20 |
MX2015002816A (es) | 2015-05-15 |
DK2895209T3 (da) | 2019-10-21 |
BR112015005335A2 (pt) | 2017-07-04 |
EP2895209B1 (en) | 2019-07-17 |
JP2015528492A (ja) | 2015-09-28 |
WO2014041543A1 (en) | 2014-03-20 |
HRP20191804T1 (hr) | 2019-12-27 |
AU2013316718A1 (en) | 2015-03-12 |
HK1212638A1 (zh) | 2016-06-17 |
KR20150082207A (ko) | 2015-07-15 |
BR112015005335B1 (pt) | 2020-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2015008627A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
MX2015016983A (es) | Moduladores del transporte nuclear y usos de los mismos. | |
NZ702663A (en) | Nuclear transport modulators and uses thereof | |
MX2016016666A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
MX2016015093A (es) | Derivados de acido boronico y sus usos terapeuticos. | |
PH12015500561A1 (en) | Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same | |
PH12015500115B1 (en) | Glucagon analogues | |
EA201591003A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
MX2015009106A (es) | Composiciones de solución sólida y su uso en el tratamiento del dolor intenso. | |
MX2013004061A (es) | Analogos de ciclosporina. | |
MX359713B (es) | Composiciones mejoradas para la cicatrizacion de heridas que comprenden microesferas. | |
PH12015502118A1 (en) | Pyridin-4-yl derivatives | |
MX2013004062A (es) | Analogos de ciclosporina. | |
MX370990B (es) | Ésteres de ácidos oligo-hidroxicarboxílicos y uso de los mismos. | |
EP2910247A4 (en) | COMPOSITIONS FOR PREVENTING OR TREATING ALLERGIC SKIN DISORDERS CONTAINING GPCR19 AGENTS AS ACTIVE INGREDIENTS | |
EP2886112A4 (en) | COMPOSITION CONTAINING AS ACTIVE INGREDIENT OF S-ALLYL-L-CYSTEINE FOR PREVENTING OR TREATING OCULAR DISEASES, AND PHARMACEUTICAL FORMULATION COMPRISING THE SAME | |
MX2014011218A (es) | Uso de agentes tensoactivos anfotericos para la prevencion y tratamiento de biopeliculas vaginales patogenas en infecciones vaginales. | |
WO2014031982A3 (en) | Methods and compositions for treating pain | |
EP2870964A4 (en) | COMPOSITION FOR THE PREVENTION OR TREATMENT OF COLITIET COMPRISING S-ALLYL-L-CYSTEINE AS ACTIVE INGREDIENT AND MEDICAL PREPARATION COMPRISING THE SAME | |
MX2016014261A (es) | Uso de acido 1,3-propandisulfonico o sales farmaceuticamente aceptables del mismo para el tratamiento de sarcoidosis. | |
TN2014000484A1 (en) | Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis. | |
NZ764041A (en) | Use of 1,3-propanedisulfonic acid or pharmaceutically acceptable salts thereof for the treatment of sarcoidosis | |
TR201203083A2 (tr) | Sefdinir ve klavulanik asit içeren farmasötik dozaj formu. | |
GB2519004A (en) | Quinone compounds and their uses for the treatment of cancer | |
TR201203085A2 (tr) | Sefetamet ve klavulanik asit içeren bileşimler. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |